Human Interferon α1b Inhalation Solution Against Respiratory Syncytial Virus in Children With Lower Respiratory Tract Infections

NCT06363370 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

322

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

DRUG: Human interferon α1b Inhalation Solution
DRUG: Inhalation Solution Placebo

Sponsor

Kexing Biopharm Co., Ltd.